Company: CWAN
Filing Date: 2025-03-06
Form Type: S-4/A
Source: 0001193125-25-048570
Chunk: 215

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-06
Form: S-4/A
Chunk 215
---
’ representatives not to, directly or indirectly (other than with respect to the Buyer Parties):

| • |     | solicit, assist, initiate, propose, induce the making, submission or announcement of, or otherwise knowingly                                                        
 encourage or facilitate any inquiries, proposals or offers that constitute, or that would reasonably be expected to constitute or lead to, an Acquisition Proposal; |

| • |     | authorize, engage in, continue or otherwise participate in any discussions or negotiations with any third party                                          
 regarding an any inquiries, proposals or offers that constitute, or that would reasonably be expected to constitute or lead to, an Acquisition Proposal; |

| • |     | furnish to any third party any information or provide to any third party access to the businesses, properties,                                                                                                                                  
 assets, books, records or personnel of Enfusion or any of its subsidiaries, in each case for the purpose of encouraging or facilitating any inquiries, proposals or offers that constitute, or that would reasonably be expected to lead to, an 
 Acquisition Proposal;                                                                                                                                                                                                                           |

| • |     | approve, endorse or recommend an Acquisition Proposal, or publicly propose to accept, approve endorse or 
 recommend any publicly announced Acquisition Proposal;                                                   |

| • |     | approve, recommend or enter into, or propose to approve, recommend or enter into, any letter of intent,                                                                                                            
 memorandum of understanding, merger agreement, acquisition agreement, or other similar contract (other than an Acceptable Confidentiality Agreement, or such other permitted confidentiality agreement pursuant to 
 no-shop provisions of the Merger Agreement) with respect to an Acquisition Proposal; or                                                                                                                            |

| • |     | propose, resolve, authorize, agree or commit to do any of the foregoing. |

In addition, from the date of the Merger Agreement until the earlier to occur of the Effective Time or the termination of the Merger Agreement, Enfusion will, and will cause its subsidiaries to, and will direct Enfusion’s and its subsidiaries’ representatives to, promptly after the execution and delivery of the Merger Agreement: (1) in any event within 24 hours of the execution and delivery of the Merger Agreement, cease and terminate any existing discussions, communications or negotiations with any third party, theretofore conducted by Enfusion, its subsidiaries or their respective representatives with respect to an Acquisition Proposal and terminate all access of any third party to any physical or electronic data room (or other diligence access) maintained by Enfusion or its representatives and (2) in any event within three business days after the execution and delivery of